التداخل بين أوماليزوماب وتريامسينولون

Corticosteroid Reduction: Do not abruptly discontinue corticosteroids upon initiation of OMLYCLO therapy.

Eosinophilic Conditions: Be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy, especially upon reduction of oral corticosteroids.

Corticosteroid Reduction Do not discontinue systemic or inhaled corticosteroids abruptly upon initiation of OMLYCLO therapy for asthma or CRSwNP.

Decrease corticosteroids gradually under the direct supervision of a physician.

These events usually, but not always, have been associated with the reduction of oral corticosteroid therapy.